Abstract: Stochastic simulations require large amounts of time to generate enough trajectories to attain statistical significance and estimate desired performance indices with satisfactory accuracy.

Brasada Capital Management, an investment management company, released its Q3 2025 investor letter. A copy of the letter can be downloaded here. In the letter, the firm noted that the market entered ...

Luminar has filed motions seeking authorization to conduct sale processes for both LSI equity and its LiDAR business, with transactions expected to complete by the end of January 2026. To fund ...

Alicia Morgans, MD, MPH, and Paul Sieber, MD, introduce the discussion, outlining goals to connect evolving mCRPC research with personalized immunotherapy practice.

Abstract: Discrete simulation is an indispensable approach to investigate systems whose complexity prohibits analytical modeling and for which real-world experimentation is costly or dangerous. To ...

Sherrod DeGrippo, Director of Threat Intelligence Strategy at Microsoft, is a frequently cited threat intelligence expert with a 19-year career leading global threat research and analyst teams. She ...

Overall survival (OS) in patients with advanced or metastatic urothelial carcinoma (UC) is not optimistic. For a long time, the standard platinum-based chemotherapy has been one of the preferred ...

Even as Taiwan's semiconductor tariff policies remain unresolved and the New Taiwan dollar continues to appreciate, major chip packaging and testing firms are showing surprising resilience. Strong ...

Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies ...

Urothelial carcinoma (UC) represents the most common pathological type of bladder cancer. For patients with locally advanced or metastatic UC (la/m UC), the standard of care with platinum-based ...

Panelists discuss how the treatment landscape for EGFR-mutant non–small cell lung cancer (NSCLC) has evolved to include 3 viable frontline options (osimertinib alone, osimertinib plus chemotherapy, ...